Clinical Trial Update: Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of daxibotulinumtoxinA for injection to treat moderate to severe glabellar lines has completed with po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Lines
• Glabellar Lines

Drugs mentioned

• DaxibotulinumtoxinA for Injection (daxibotulinumtoxinA)

Snippet

Sponsor: Revance Therapeutics, Inc. | Conditions: Glabellar Frown Lines | Phase 3 | Status: COMPLETED | Results posted: 2022-07-21